Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-24

FDA Approved: TERIFLUNOMIDE — Original Application (MSN LABORATORIES PRIVATE LIMITED)

View source ↗

Summary

FDA approved the original application for a generic teriflunomide from MSN Laboratories Private Limited, indicated for relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)